Indegene exceeded co-promotion expectations for 3 mature ophthalmology brands of a global pharmaceutical company shifting salesforce focus to new pipeline launches amid revenue declines. Challenges included stabilizing revenue, improving market share, and proving concept within 6 months for its 7-brand ophthalmology/PCP portfolio. Indegene's software precisely segmented HCP targets from proprietary and client data by Rx likelihood and digital affinity, enabling targeted engagement strategies that rapidly restored growth, validated the model, and delivered superior performance beyond expectations.

Join for free to read